adenine has been researched along with Bone Diseases, Metabolic in 11 studies
Bone Diseases, Metabolic: Diseases that affect the METABOLIC PROCESSES of BONE TISSUE.
| Excerpt | Relevance | Reference |
|---|---|---|
| " He had been receiving low-dose adefovir dipivoxil (ADV) for the treatment of lamivudine-resistant chronic hepatitis B virus infection for eight years and subsequently developed severe hypophosphatemia and proximal renal tubule dysfunction." | 8.90 | Hypophosphatemic osteomalacia due to drug-induced Fanconi's syndrome associated with adefovir dipivoxil treatment for hepatitis B. ( Eguchi, H; Hiromatsu, Y; Kuwahara, R; Tani, J; Tsuruta, M, 2014) |
| "Adefovir dipivoxil is commonly used for treatment of chronic hepatitis B." | 7.77 | [Adefovir dipivoxil-induced Fanconi syndrome and hypophosphatemic osteomalacia associated with muscular weakness in a patient with chronic hepatitis B]. ( Dong, GF; Li, L; Xie, YS; Zhang, X, 2011) |
| " He had been receiving low-dose adefovir dipivoxil (ADV) for the treatment of lamivudine-resistant chronic hepatitis B virus infection for eight years and subsequently developed severe hypophosphatemia and proximal renal tubule dysfunction." | 4.90 | Hypophosphatemic osteomalacia due to drug-induced Fanconi's syndrome associated with adefovir dipivoxil treatment for hepatitis B. ( Eguchi, H; Hiromatsu, Y; Kuwahara, R; Tani, J; Tsuruta, M, 2014) |
| "Combined nutrients supplementation with omega-3 FA and MK-7 may be helpful for aortic VC prevention, reducing osteoclast activation and improving sarcopenia-related molecules in adenine and low-protein diet induced uremic rats." | 4.12 | Omega-3 fatty acid and menaquinone-7 combination are helpful for aortic calcification prevention, reducing osteoclast area of bone and Fox0 expression of muscle in uremic rats. ( An, WS; Jeong, EG; Jeong, YI; Kim, SE; Lee, SM; Rha, SH, 2022) |
| " Here, we established a rat model with secondary hyperparathyroidism (SHPT) and bone disease induced by adenine and a high phosphorous diet and analyzed the skeletal characteristics." | 3.88 | A rat model of SHPT with bone abnormalities in CKD induced by adenine and a high phosphorus diet. ( Chen, Q; Liu, BC; Lv, LL; Ni, HF; Ni, LH; Song, KY; Tang, RN; Wang, B; Wang, FM; Wang, LT; Wu, M, 2018) |
| "Adefovir dipivoxil is commonly used for treatment of chronic hepatitis B." | 3.77 | [Adefovir dipivoxil-induced Fanconi syndrome and hypophosphatemic osteomalacia associated with muscular weakness in a patient with chronic hepatitis B]. ( Dong, GF; Li, L; Xie, YS; Zhang, X, 2011) |
| "Tenofovir disoproxil fumarate is the first-line antiviral therapy for chronic viral hepatitis B, but long-term use is associated with renal failure and hypophosphatemic osteomalacia." | 2.82 | Tenofovir-induced osteopenia and hyperparathyroidism: A case report and literature review. ( Li, L; Ma, W; Wei, D; Ye, P; Zeng, J, 2022) |
| "Although osteopenia is common in HIV-infected patients, there is by now limited data on the evolution of bone mineral density in this population." | 1.39 | Changes in bone mineral density over a 2-year period in HIV-1-infected men under combined antiretroviral therapy with osteopenia. ( Assoumou, L; Bentata, M; Costagliola, D; Katlama, C; Kolta, S; Roux, C; Rozenberg, S; Simon, A; Viard, JP, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 6 (54.55) | 24.3611 |
| 2020's | 4 (36.36) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, SM | 1 |
| Jeong, EG | 1 |
| Jeong, YI | 1 |
| Rha, SH | 1 |
| Kim, SE | 1 |
| An, WS | 1 |
| Zeng, J | 1 |
| Ye, P | 1 |
| Wei, D | 1 |
| Li, L | 2 |
| Ma, W | 1 |
| David, K | 1 |
| Dubois, V | 1 |
| Verhulst, A | 1 |
| Sommers, V | 1 |
| Schollaert, D | 1 |
| Deboel, L | 1 |
| Moermans, K | 1 |
| Carmeliet, G | 1 |
| D'Haese, P | 1 |
| Vanderschueren, D | 1 |
| Claessens, F | 1 |
| Evenepoel, P | 1 |
| Decallonne, B | 1 |
| Metzger, CE | 1 |
| Swallow, EA | 1 |
| Stacy, AJ | 1 |
| Allen, MR | 1 |
| Ni, LH | 1 |
| Tang, RN | 1 |
| Lv, LL | 1 |
| Wu, M | 1 |
| Wang, B | 1 |
| Wang, FM | 1 |
| Ni, HF | 1 |
| Song, KY | 1 |
| Wang, LT | 1 |
| Chen, Q | 1 |
| Liu, BC | 1 |
| Assoumou, L | 1 |
| Katlama, C | 1 |
| Viard, JP | 1 |
| Bentata, M | 1 |
| Simon, A | 1 |
| Roux, C | 1 |
| Kolta, S | 1 |
| Costagliola, D | 1 |
| Rozenberg, S | 1 |
| Eguchi, H | 1 |
| Tsuruta, M | 1 |
| Tani, J | 1 |
| Kuwahara, R | 1 |
| Hiromatsu, Y | 1 |
| Hamnvik, OP | 1 |
| Becker, CB | 1 |
| Levy, BD | 1 |
| Loscalzo, J | 1 |
| Ferrari, GO | 1 |
| Ferreira, JC | 1 |
| Cavallari, RT | 1 |
| Neves, KR | 1 |
| dos Reis, LM | 1 |
| Dominguez, WV | 1 |
| Oliveira, EC | 1 |
| Graciolli, FG | 1 |
| Passlick-Deetjen, J | 1 |
| Jorgetti, V | 1 |
| Moysés, RM | 1 |
| Dong, GF | 1 |
| Zhang, X | 1 |
| Xie, YS | 1 |
| Funke, S | 1 |
| Morava, E | 1 |
| Czakó, M | 1 |
| Vida, G | 1 |
| Ertl, T | 1 |
| Kosztolányi, G | 1 |
2 reviews available for adenine and Bone Diseases, Metabolic
| Article | Year |
|---|---|
Tenofovir-induced osteopenia and hyperparathyroidism: A case report and literature review.
Topics: Adenine; Bone Diseases, Metabolic; Calcium; Humans; Hyperparathyroidism, Primary; Hyperparathyroidis | 2022 |
Hypophosphatemic osteomalacia due to drug-induced Fanconi's syndrome associated with adefovir dipivoxil treatment for hepatitis B.
Topics: Adenine; Bone Diseases, Metabolic; Fanconi Syndrome; Hepatitis B, Chronic; Humans; Hypophosphatemia; | 2014 |
9 other studies available for adenine and Bone Diseases, Metabolic
| Article | Year |
|---|---|
Omega-3 fatty acid and menaquinone-7 combination are helpful for aortic calcification prevention, reducing osteoclast area of bone and Fox0 expression of muscle in uremic rats.
Topics: Adenine; Animals; Aortic Diseases; Bone Diseases, Metabolic; Drug Therapy, Combination; Fatty Acids, | 2022 |
Androgen therapy does not prevent bone loss and arterial calcifications in male rats with chronic kidney disease.
Topics: Adenine; Androgens; Animals; Bone Diseases, Metabolic; Dihydrotestosterone; Hypogonadism; Male; Rats | 2023 |
Adenine-induced chronic kidney disease induces a similar skeletal phenotype in male and female C57BL/6 mice with more severe deficits in cortical bone properties of male mice.
Topics: Adenine; Animals; Bone and Bones; Bone Diseases, Metabolic; Cortical Bone; Diet; Disease Models, Ani | 2021 |
A rat model of SHPT with bone abnormalities in CKD induced by adenine and a high phosphorus diet.
Topics: Adenine; Animals; Bone and Bones; Bone Density; Bone Diseases; Bone Diseases, Metabolic; Diet; Disea | 2018 |
Changes in bone mineral density over a 2-year period in HIV-1-infected men under combined antiretroviral therapy with osteopenia.
Topics: Absorptiometry, Photon; Adenine; Adult; Anti-HIV Agents; Anti-Retroviral Agents; Bone Density; Bone | 2013 |
Clinical problem-solving. Wasting away.
Topics: Adenine; Adult; Bone Diseases, Metabolic; Cachexia; Diagnosis, Differential; Fanconi Syndrome; Femal | 2014 |
Mineral bone disorder in chronic kidney disease: head-to-head comparison of the 5/6 nephrectomy and adenine models.
Topics: Adenine; Animals; Bone Diseases, Metabolic; Calcification, Physiologic; Calcium; Disease Models, Ani | 2014 |
[Adefovir dipivoxil-induced Fanconi syndrome and hypophosphatemic osteomalacia associated with muscular weakness in a patient with chronic hepatitis B].
Topics: Adenine; Antiviral Agents; Bone Diseases, Metabolic; Fanconi Syndrome; Hepatitis B, Chronic; Humans; | 2011 |
[Metabolic bone disease in premature infants and genetic polymorphisms].
Topics: Adenine; Alkaline Phosphatase; Biomarkers; Bone and Bones; Bone Density; Bone Diseases, Metabolic; B | 2007 |